Chromous Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 3.50 M
- Company Age 18 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.07 Cr
- Satisfied Charges ₹ 1.85 Cr
- Revenue Growth -21.09%
- Profit Growth -59.95%
- Ebitda 35.65%
- Net Worth 1.00%
- Total Assets 19.89%
About Chromous Biotech
Chromous Biotech Private Limited (CBPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 November 2006 and has a history of 18 years and two months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.50 M.
The company currently has active open charges totaling ₹2.07 Cr. The company has closed loans amounting to ₹1.85 Cr, as per Ministry of Corporate Affairs (MCA) records.
Venkita Subbulakshmi and Biswajit Roy serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33127KA2006PTC040966
- Company No.
040966
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Nov 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Chromous Biotech?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Biswajit Roy | Managing Director | 17-Nov-2006 | Current |
Board Members (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Venkita Subbulakshmi | Director | 09-Jul-2018 | Current |
Financial Performance of Chromous Biotech.
Chromous Biotech Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 21.09% decrease. The company also saw a substantial fall in profitability, with a 59.95% decrease in profit. The company's net worth moved up by a moderate rise of 1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Chromous Biotech?
In 2019, Chromous Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹20.74 M
₹18.50 M
Charges Breakdown by Lending Institutions
- Department Of Biotechnology : 1.62 Cr
- Others : 0.45 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
28 Mar 2019 | Others | ₹4.50 M | Open |
25 Apr 2012 | Department Of Biotechnology | ₹4.40 M | Open |
01 Mar 2012 | Department Of Biotechnology | ₹1.18 Cr | Open |
30 Dec 2008 | Corporation Bank | ₹1.85 Cr | Satisfied |
How Many Employees Work at Chromous Biotech?
Chromous Biotech has a workforce of 5 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chromous Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chromous Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.